| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.67▼ | 1.67▼ | 1.67▼ | 1.46▲ | 1.24▲ |
| MA10 | 1.66▼ | 1.64▼ | 1.62▼ | 1.32▲ | 1.35▲ |
| MA20 | 1.54▲ | 1.50▲ | 1.46▲ | 1.23▲ | 1.68▼ |
| MA50 | 1.37▲ | 1.30▲ | 1.30▲ | 1.38▲ | 2.45▼ |
| MA100 | 1.30▲ | 1.35▲ | 1.38▲ | 1.72▼ | N/A |
| MA200 | 1.40▲ | 1.54▲ | 1.62▼ | 2.20▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.005▲ | 0.014▲ | 0.070▲ | 0.142▲ |
| RSI | 55.269▲ | 58.122▲ | 59.586▲ | 61.412▲ | 35.919▼ |
| STOCH | 63.413 | 69.109 | 75.518 | 78.698 | 24.511 |
| WILL %R | -53.247 | -47.674 | -46.067 | -40.476 | -48.135 |
| CCI | -8.674 | 7.726 | 19.635 | 184.238▲ | -7.190 |
|
Thursday, May 01, 2025 04:30 AM
Tharimmune, Inc., (Nasdaq:THAR) (”Tharimmune” or the “Company”) a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology announced ...
|
|
Wednesday, April 30, 2025 05:06 AM
Tharimmune, Inc., (NASDAQ:THAR) (”Tharimmune” or the “Company”) a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology, today announced ...
|
|
Tuesday, April 29, 2025 04:59 PM
BRIDGEWATER, NJ / ACCESS Newswire / April 15, 2025 / Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.76 | 1.89 | 1.51 | 1.55 | 323,970 |
| 30/04/25 | 1.63 | 1.75 | 1.48 | 1.73 | 539,054 |
| 29/04/25 | 1.37 | 1.495 | 1.36 | 1.47 | 265,285 |
| 28/04/25 | 1.20 | 1.40 | 1.095 | 1.36 | 1,920,825 |
| 25/04/25 | 1.23 | 1.23 | 1.19 | 1.1999 | 7,921 |
| 24/04/25 | 1.28 | 1.28 | 1.205 | 1.205 | 6,968 |
| 23/04/25 | 1.17 | 1.2397 | 1.16 | 1.2052 | 12,147 |
| 22/04/25 | 1.19 | 1.19 | 1.12 | 1.1697 | 6,428 |
| 21/04/25 | 1.13 | 1.26 | 1.05 | 1.15 | 21,585 |
| 17/04/25 | 1.12 | 1.13 | 1.115 | 1.1299 | 4,251 |
|
|
||||
|
|
||||
|
|